Brief: Polyphor Presents New Data At ECCMID From Its Lead Antibiotic Murepavadin And New Ompta Pol7306
April 17 (Reuters) - Polyphor AG POLN.S :
* POLYPHOR PRESENTS NEW DATA AT ECCMID FROM ITS LEAD
ANTIBIOTIC
MUREPAVADIN AND NEW OMPTA POL7306
Source text for Eikon: ID:nEQ5dtlxna
Further company coverage: POLN.S
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Spexis AG
See all newsBrief: Spexis AG: Expects Audit Of 2023 Financials Will Not Be Completed By 31 July 2024
Brief: Spexis Launches Appeal Against Six Exchange Regulation Decision To Suspend Trading Of Its Shares.
Brief: Spexis AG- Audit Costs Have Not Been Approved Yet And Further Extension May Be Required
Brief: Spexis Announces CFO Hernan Levett Has Decided To Pursue New Career Outside Company
Brief: Spexis: Total Loss Of CHF 3.9 Mln In H1 2023